Nu Skin (NUS) AI Stock Analysis
Nu Skin
(BMV:NUS)
No summary available
Nu Skin (NUS) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- MXN 226.35M
- Dividend Yield
- 4.95%
- Average Volume (3M)
- 250
- Price to Earnings (P/E)
- -1.0
- Beta (1Y)
- 0.70
- Revenue Growth
- -15.44%
- EPS Growth
- -319.79%
- Country
- Mexico
- Employees
- 2,800
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Household & Personal Products
Nu Skin Business Overview & Revenue Model
Company Description
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageL...
Nu Skin Earnings Call Summary
The call presented a mixed picture: strong product momentum and engagement around Prysm iO, improved core gross margin, cost reductions in G&A, and disciplined liquidity position are notable positives. However, sizable non-cash goodwill and deferred tax charges materially impacted reported earnings, adjusted operating margins declined, recruiting and leadership development remain weak, and the India launch was delayed. Near-term FX headwinds and modest operating cash flow further temper the outlook. On balance, the company shows encouraging strategic traction and product adoption but faces meaningful near-term financial and operational headwinds.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Nu Skin updated Q3 revenue guidance to $310–$340 million (with an expected 2–3% foreign currency headwind) and Q3 EPS of $0.00–$0.09 reported (adjusted $0.10–$0.20), and revised full‑year revenue to $1.28–$1.35 billion (≈1% FX headwind) with reported FY EPS of −$4.90 to −$4.73 (adjusted $0.70–$0.90) and an adjusted effective tax rate of ~35%; management expects to place 50,000–60,000 Prysm iO devices by year‑end (vs. >39,000 placed to date, up ~30% QoQ, and 2.5 million scans, up ~25% QoQ). The company plans $5–$10 million of cash‑based organizational transition costs through year‑end excluded from adjusted results and also excluded the Q2 non‑cash charges (a $78.9M goodwill impairment and a $167.5M deferred tax valuation allowance) from adjusted guidance; for context Q2 revenue was $320.1M, gross margin 68.2% (core 77.7%), adjusted operating margin 6.1%, cash $189.6M, debt $213.7M and Q2 operating cash flow $10.6M.
Nu Skin Risk Analysis
Nu Skin disclosed 12 risk factors in its most recent earnings report. Nu Skin reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
1 New RiskNu Skin Peers Comparison
Overall Rating
HNST69Neutral
ELF65Neutral
EL58Neutral
YSG49Neutral
ODD43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | $447.38M | -40.25 | -6.99% | ― | -12.26% | -282.39% | |
| 65Neutral | $6.59B | 111.54 | 5.18% | ― | 31.23% | -42.14% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 58Neutral | $39.58B | 214.18 | 4.63% | 1.28% | 5.51% | ― | |
| 49Neutral | $211.05M | -6.89 | -7.20% | ― | 25.10% | 59.14% | |
| 43Neutral | $999.52M | 72.23 | 4.60% | ― | -9.68% | -84.42% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MX:NUS | Nu Skin Enterprises | 81.00 | -101.16 | -55.53% | |
| EL | Estée Lauder | 109.23 | 17.29 | 18.80% | |
| ELF | e.l.f. Beauty, Inc. | 111.69 | -9.25 | -7.65% | |
| YSG | Yatsen Holding Ltd. | 2.25 | -4.17 | -64.95% | |
| HNST | Honest Company, Inc. | 4.17 | 0.81 | 24.11% | |
| ODD | ODDITY Tech Ltd. Class A | 21.67 | -22.21 | -50.62% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.